INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES
-
![AI, artificial intelligence-GettyImages-2205274485]( "Early-Stage Biotech's AI Advantage Is A Window That Closes")
Early-Stage Biotech's AI Advantage Is A Window That ClosesThe "greenfield" advantage allows biotechs to build AI-native trials from the start, replacing manual data entry with automated workflows and structured human oversight for better data integrity.
-
![Senior man at clinic reception desk-GettyImages-2174582061]( "The Budget Line Item That Could Make Or Break Retention")
The Budget Line Item That Could Make Or Break RetentionA participant's preferred payment method can make or break retention. Learn how flexible, participant-friendly compensation benefits both study volunteers and trial success.
-
![GettyImages-2155531148 electronic data, ePRO, eCOA]( "The Science Behind Medable's Health Economics And Outcomes Research")
The Science Behind Medable's Health Economics And Outcomes ResearchMeet the team responsible for ensuring the scientific rigor and outcomes of Medable’s clinical trial platform, and uncover how they’ve been pioneering eCOA and ePRO research for decades.
-
![GettyImages-1331910730 payment]( "How Do Site Payments Impact Clinical Trial Sustainability?")
How Do Site Payments Impact Clinical Trial Sustainability?Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,
-
Five Questions Biotechs Should Ask Before Selecting A Bioanalytical CRO9/2/2025
In a landscape where speed, quality, and trust are inseparable, choosing a CRO that shares your ambition is not optional; it is essential to survival and success.
-
Digital Endpoint Resource Guide: Obesity And Related Metabolic Disorders8/15/2024
Explore how digital health technologies can enhance obesity treatment by providing critical insights beyond weight loss.
-
How To Prepare Your Life Sciences Company For A Successful IPO11/14/2024
When you're preparing for an IPO it's important to consider transitioning to a scalable ERP system, enabling your life science company to efficiently handle financial data.
-
How To Improve Patient Outcomes Using eSource Software In Clinical Trials8/11/2025
As the demand for patient-centric clinical trials grows, eSource platforms will play an increasingly vital role in facilitating efficient, compliant, and innovative research methodologies.
-
Sikich Success For Life Sciences4/3/2025
Explore an innovative solution for early-stage Life Sciences Organizations featuring dimensional charts of accounts, program and project management, multi-subsidiary support, and mass securities.
CLINICAL TRIAL TECHNOLOGY SOLUTIONS
-
![trailkit econsent]( "eConsent For Clinical Trials")
Electronic informed consent for patient-centric decentralized clinical trials.
-
![GettyImages-1142752574-team-collaboration-computer-research]( "A Simplified, Accessible Solution For Phase I And Phase IV Trials")
Rave Lite is an efficient, cost-effective solution tailored for Phase I and Phase IV clinical trials. This technology simplifies data capture, management, and analysis, enabling accelerated study timelines.
-
![GettyImages-1483243079-doctors-data-computer-analysis-tablet-office]( "Bridging The Gap Between EHR And EDC")
Clinical trial sites have long relied on manual, error-prone processes to transfer patient data from EHRs into EDC systems, but integrated solutions make streamlining this workflow quick and simple.
-
![Global communications network-iStock-1255527368]( "Coming Soon! TrialScope Atlas")
TrialScope Atlas enables clinical trial sponsors to quickly and accurately answer the question: Am I сompliant? Atlas reduces the risk of disclosure noncompliance by providing real-time access to consolidated, global compliance performance metrics.
-
![GettyImages-2081140990-phone-cellphone-hand]( "Visit Management Solution Built For Global Trials")
From reminders to resource coordination, visit scheduling shouldn't slow trials down. Discover how automation can reduce deviations and support participants.
